Lee Agnes Y Y
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Vnitr Lek. 2006 Mar;52 Suppl 1:127-8, 130-1.
Venous thromboembolism (VTE) is a common problem in patients with cancer that complicates management and predicts for a worse prognosis. Hence, effective methods to prevent and treat VTE can reduce morbidity and mortality. Low molecular weight heparins have simplified and improved management of VTE and recent studies suggest these agents may improve survival in cancer patients. This review will provide an update on the primary prevention and treatment of VTE, as well as prophylaxis for central venous catheters, in patients with malignancy.
静脉血栓栓塞症（VTE）是癌症患者中常见的问题，它会使治疗变得复杂，并预示着更差的预后。因此，预防和治疗VTE的有效方法可以降低发病率和死亡率。低分子量肝素简化并改善了VTE的治疗，最近的研究表明这些药物可能会提高癌症患者的生存率。本文将对恶性肿瘤患者VTE的一级预防、治疗以及中心静脉导管的预防进行更新。
